Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients

Epilepsy Research

Volumn 38, Issue 2-3, 2000, Pages 151-160

  Jambaque I ^a,b,c   Chiron, C ^a,b,c   Dumas, C ^d   Mumford, J ^d   Dulac, O ^a,b,c  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SANOFI   (France)

Author keywords

Autism; Cognitive functions; Infantile spasms; Tuberous sclerosis; Vigabatrin

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; NITRAZEPAM; PHENYTOIN; PROGABIDE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; EPILEPSY; FOLLOW UP; HUMAN; INFANT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

ANTICONVULSANTS; AUTISTIC DISORDER; CHILD BEHAVIOR DISORDERS; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERKINESIS; INFANT; INFANT, NEWBORN; INTELLIGENCE TESTS; LEARNING DISORDERS; MALE; MENTAL RETARDATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; SPASMS, INFANTILE; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; VIGABATRIN;

EID: 0033991818     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00082-0     Document Type: Article

References (33)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th edition:1994;APA, Washington DC.
2. Bolton P.F., Griffiths P.D. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet. 349:1997;392-395.
3. Brunet O., Lezine I. Le developpement psychologique de la premiere enfance. 1983;1-174 EAP, Paris.
4. Burd L., Kerbeshian J., Fischer W. Does the use of phenobarbital as an anticonvulsivant permanently exacerbate hyperactivity? Can. J. Psych. 32:1987;10-13.
5. Cesselin F. Comment evaluer le niveau intellectuel. Terman Merrill. 1988;1-142 EAP, Paris.
6. Chevrie-Muller C., Simon A.M., Decante P. Epreuves pour l'examen du langage. 1981;1-139 EAP, Paris.
7. Chiron C., Dulac O., Beaumont D., Palacios L., Pajot N., Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J. Child Neurol. 6:1991;S5259.
8. Chiron C., Dumas C., Jambaque I., Mumford J., Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epil. Res. 26:1997;389-395.
9. Curran H.V. Tranquillising memories: a review of the effects of benzodiazepines on human memories. Biol. Psychol. 23:1986;179-213.
10. Cusmai R., Chiron C., Curatolo P., Dulac O, Tran-Dinh S. A topographic comparative study on MRI an EEG in 34 children with tuberous sclerosis. Epilepsia. 31:1990;747-755.
11. Dellatolas G., De Agostini M., Jallon P., Poncet M., Rey M., Lellouch J. Mesure de la preference manuelle par autoquestionnaire dans la population francaise adulte. Revue de Psychologie Appliquee. 38:1988;117-136.
12. Frostig M. Test de developpement de la perception visuelle. 1973;1-74 EAP, Paris.
13. Gillberg I.C., Gillberg C., Ahlsen G. Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev. Med. Child Neurol. 36:1994;50-56.
14. Gomez M.R. Neurologic and Psychiatric Features. Gomez M.R. Tuberous Sclerosis. Second Edition:1988;21-36 Raven, New York.
15. Herranz J.L., Armijo J.A., Artega R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine and valproate during monotherapy in children. Epilepsia. 29:1988;794-804.
16. Hunt A., Dennis J. Psychiatric disorder among children with tuberous sclerosis. Dev. Med. Child Neurol. 29:1987;190-198.
17. Jambaque I., Cusmai R., Curatolo P., Cortesi F., Perrot C., Dulac O. Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings. Dev. Med. Child Neurol. 33:1991;698-705.
18. Jambaque I., Chiron C., Dulac O., Raynaud C., Syrota A. Visual inattention in West syndrome: a neuropsychologic and neurofunctional imaging study. Epilepsia. 34:1993;692-700.
19. Kalviaanen R., Aikia M., Patanen J., Silvenius J., Mumford J., Sakala M., Riiekkinen P.J. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J. Child Neurol. 6:1991;S60-S69.
20. Koo B., Hwang P.A., Logan W.J. Infantile spasms: outcome and pronostic factors of cryptogenic and symptomatic groups. Neurology. 43:1993;2322-2327.
21. Lane V.W., Samples J.M. Tuberous sclerosis: Case study of early seizure control and subsequent normal development. J. Autism Dev. Disorders. 4:1984;423-427.
22. McCarthy D. Echelles d'aptitudes pour enfants de McCarthy. 1976;1-204 EAP, Paris.
23. McGuire A.M., Duncan J.S., Trimble M.R. Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy. Epilepsia. 33:1992;128-134.
24. Nabbout R., Chiron C., Mumford J., Dumas C., Dulac O. Vigabatrin in partial seizures in children. J. Child Neurol. 12:1997;172-177.
25. Rey A. Test de copie d'une figure complexe. 1959;1-24 EAP, Paris.
26. Riikonen R., Amnell G. Psychiatric disorders in children with earlier infantile spasms. Dev. Med. Child Neurol. 23:1981;747-760.
27. Riikonen R., Simell O. Tuberous sclerosis and infantile spasms. Dev. Med. Child Neurol. 32:1990;203-209.
28. Shepherd C.W., Stephenson J.P.B. Seizures and intellellectual disability associated with tuberous sclerosis complex in the West of Scotland. Dev. Med. Child Neurol. 34:1992;766-774.
29. Sirvio J., Ylinen A., Lahtinen H., Ronkainen A., Riekkienen P., Halonen T., Riekkienen P.J. The effects of vigabatrin on learning and memory in non-epileptic rats. Pharmacol. Biochem. Behav. 39:1991;205-210.
30. Trimble M.R., Cull C. Children of school age: the influence of antiepileptic drugs and behaviour and intellect. Epilepsia. 29:1988;S15-S19.
31. Wechsler D. Echelle d'intelligence de Wechsler pour la periode pre-scolaire et primaire (WPPSI). 1974;1-164 EAP, Paris.
32. Wechsler D. Echelle d'intelligence de Wechsler pour enfants-Forme Revisee. 1981;1-221 EAP, Paris.
33. Wing L., Gould J. Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification. J. Autism Dev. Disorders. 9:1979;11-29.